Is this your podcast?
Sign up
to track ranks and reviews from Spotify, Apple Podcasts and more
2015 ASCO Annual Meeting
Listen now
Recent Episodes
Dr Chowdhury talks to ecancertv at ASCO 2015 about the results of the TERRAIN study which looked at the use of 160 mg of enzalutamide taken orally once daily versus bicalutamide at a dose of 50mg taken once daily in combination with an LHRH analogue in patients with metastatic prostate cancer...
Published 08/08/17
Dr Schilsky presents, at a press conference at ASCO 2015, the Targeted Agent and Profiling Utilization Registry (TAPUR).
It is the first ASCO-led clinical trial, which will offer patients with advanced cancer access to molecularly-targeted cancer drugs and collect "real-world" data on clinical...
Published 08/08/17
Prof Wu talks to ecancertv at ASCO 2015 about EGFR inhibition in lung cancer.
Published 08/08/17
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
Links
No website
No RSS feed
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
